Bioptik TechnologyROCO:4161 68 Quick Ratio is 1.51 as of Dec. 2025, which is 1% above its 10-year median of 1.49. GuruFocus rates ROCO:4161 with a GF Score™ of 68/100 and a GF Value™ of NT$27.79 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Bioptik Technology ranks worse than 61.17% on this metric.
Bioptik Technology has a quick ratio of 1.51. It generally indicates good short-term financial strength.
The historical rank and industry rank for Bioptik Technology's Quick Ratio or its related term are showing as below:
ROCO:4161'
s Quick Ratio Range Over the Past 10 Years
Min: 0.91 Med: 1.49 Max: 2.27
Current: 1.51
During the past 13 years, Bioptik Technology's highest Quick Ratio was 2.27. The lowest was 0.91. And the median was 1.49.
ROCO:4161's Quick Ratio is ranked worse than 61.17% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs ROCO:4161: 1.51
Bioptik Technology (ROCO:4161) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Bioptik Technology Quick Ratio Related Terms
Bioptik Technology Quick Ratio Historical Data
* Premium members only.
The historical data trend for Bioptik Technology's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4161 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Bioptik Technology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioptik Technology Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Bioptik Technology's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Bioptik Technology's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioptik Technology (ROCO:4161) has a Quick Ratio of 1.51 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bioptik Technology and its competitors. This is near median its historical median of 1.49. Over the past decade, Bioptik Technology's Quick Ratio has ranged from 0.91 to 2.27. According to the industry distribution chart, Bioptik Technology ranks #523 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 61.2%.
Is Bioptik Technology's Quick Ratio too high?
Bioptik Technology's current Quick Ratio of 1.51 is near median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 2.27. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Bioptik Technology's value of 1.51 is 20.1% below this industry median. Based on the distribution chart, Bioptik Technology ranks #523 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bioptik Technology has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioptik Technology's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bioptik Technology ranks #523 out of 855 companies for Quick Ratio. This places Bioptik Technology in the lower half of its industry. The industry median Quick Ratio is 1.89. Bioptik Technology's value of 1.51 is 20.1% below this benchmark. Historically, Bioptik Technology's own Quick Ratio has ranged from 0.91 to 2.27 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 1.89, Bioptik Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioptik Technology's current Quick Ratio of 1.51 is 20.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bioptik Technology and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioptik Technology's current Quick Ratio is 1.51, which is near median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioptik Technology stock overvalued right now?
Based on GuruFocus' analysis, Bioptik Technology (ROCO:4161) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.79, compared to a current price of NT$23.00 — trading 17.2% below its estimated fair value. The current Quick Ratio is 1.51, which is near median its 10-year median of 1.49 and 20.1% below the Medical Devices & Instruments industry median of 1.89. Bioptik Technology's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bioptik Technology (ROCO:4161), the current Quick Ratio is 1.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioptik Technology (ROCO:4161) Overvalued in 2026?
Based on GuruFocus' analysis, Bioptik Technology stock appears to be undervalued.
The current stock price of NT$23.00 is trading 17.2% below its estimated GF Value™ of NT$27.79.
GuruFocus considers Bioptik Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4161:
Quick Ratio: 1.51 (near median its 10-year median of 1.49)
GF Value™: NT$27.79 vs. price of NT$23.00 (17.2% below fair value)
Industry Position: 20.1% below the Medical Devices & Instruments median (#523 of 855)
No single metric tells the full story. See the ROCO:4161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
68GF Score
Get the complete analysis for ROCO:4161
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4161 has been successfully added to your 
